NEW YORK (TheStreet) -- If you're a current Body Central (BODY) - Get Report investor Monday's press release must have felt like the button on your pants broke at the moment you started an important meeting.
Body Central has lost about 65% of its market cap from a year ago and all of it within the past six weeks. Body Central's CEO Allen Weinstein (no relation to author) announced writedowns due to slow moving inventory and an impact on earnings guidance. Today's guidance revision is only six weeks after the last earnings release. Weinstein stated:
"Our second quarter comparable sales remain soft and have not improved since April. We continue to diligently manage inventory and to take aggressive markdowns on slow moving items. As a result, we now expect second quarter sales and gross margin to be lower than contemplated in our May 3rd release"
The soft economy is allowing
to execute well; however, they are not the only ones.
are both up with conviction from a year ago.
Based on my experience with gap downs following reductions in guidance similar to Body Central, investors may not see the short-term low until Tuesday or Wednesday. With Monday's closing price of $8.22 only 15 cents off the low of the day, more downside pressure is likely.
Bargain hunters and short sellers covering positions could push the price up about 30% to 50% in relation to the gap down price this week. Looking at the chart, I expect short-term resistance near $12.
Round numbers often attract like a price magnet and repel, causing a bounce. Expect a lot of volume to trade near $8 a share Tuesday, but also be prepared for bargain hunters to start positions under $8 as an entry. Body Central doesn't have debt and the price-to-earnings multiple is under 10.
If you are looking for Monday's drop to signal a buying opportunity, you are more likely going to find it at the end of the day Tuesday or opening on Wednesday. There is no hurry jumping on board with Body Central. Stocks dumping as a result of lowered guidance usually take a full two good earnings quarters to recover. Take your time and do your homework before allocating capital here. Look for the second break above $12 as the one that "sticks."
Want to see the result of a classic earnings miss a few weeks after the fact? Take a look at
. Pandora disappointed and traded from $14 down to an intraday low under $8. Also, take close note of the next few days after earnings. This is a classic pattern that is easy to see. Simply use your software to look at charts from the past few quarters and review the ones that gapped down the next day. The high placed a couple of days after the gap down in Pandora is now resistance.
Operating margins, while already low compared to Limited and Ross stores, appear closer to Wal-Mart and Target. Without a strong holiday season, an operating margin drop below the Gap and closer to
may become a reality.
A more recent earnings gap down is
. Dell disappointed and traded from $15 down to an intraday low of $12.31. Also, take close note of the next few days after earnings. The high placed a couple of days after the gap down in Dell is now resistance.
Pandora also took more than two months in recovery to reach the gap down price. Pandora, like Dell, will take about six months to trade again at pre-gap pricing, if the next two reports are favorably received by investors. I love listening to Pandora; but I am not ready to invest just yet.
For the second quarter of fiscal 2012, Body Central is now expecting a drop of 7% to 9% in comparable sales, and earnings per share of 19 cents to 21 cents based on 16.4 million shares.
For the full fiscal year, the company now expects net revenue in the range of $323 million to $328 million, comparable sales to decrease in a range of 4% to 6% and diluted earnings per share in the range of $1.07 to $1.11, based on 16.4 million shares.
What's the best play with BODY? There should be a very attractive trade coming up Tuesday and or Wednesday. Near the end of the day if still trading lower, sell out of the money puts (if trading, liquidity is higher, but still slow). Fear of continued losses tends to push portfolio insurance prices up dramatically, while at the same time the stock should bottom.
This stock is not one to get greedy with; hold on for a few days and as the implied volatility falls (hopefully with a nice dead cat bounce) exit out with a quick hit and run for profits. Otherwise for longer term investors, the best play is to wait until we are closer to the next earnings release for an entry.
This article is commentary by an independent contributor, separate from TheStreet's regular news coverage.
At the time of publication, the author held no positions in any stock mentioned.